MedTrace Logo

Surgery Alone Versus Methotrexate Before Surgery in Cesarean Scar Pregnancy

NCT04379219 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2020-05-07

No results posted yet for this study

Summary

There are no universal treatment guidelines available. The ultimate purpose of the management of CSP is to simultaneously remove the pregnancy and successfully preserve the woman's fertility (Gonzalez \& Tulandi, 2017). A variety of medical and surgical treatment modalities for CSP have been reported; however, most of these are based on low-level evidence(Sun et al., 2019).

Conditions

  • Cesarean Scar Pregnancy

Interventions

DRUG

Methotrexate

giving methotrexate at least 1 w week before surgery

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • Maher Elgaly · Mansoura University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-01
Primary Completion
2020-08-31
Completion
2020-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04379219 on ClinicalTrials.gov